Transmission of Ebola viruses: what we know and what we do not know.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 4358015)

Published in MBio on February 19, 2015

Authors

Michael T Osterholm1, Kristine A Moore2, Nicholas S Kelley2, Lisa M Brosseau3, Gary Wong4, Frederick A Murphy5, Clarence J Peters5, James W LeDuc5, Phillip K Russell6, Michel Van Herp7, Jimmy Kapetshi8, Jean-Jacques T Muyembe8, Benoit Kebela Ilunga9, James E Strong4, Allen Grolla4, Anja Wolz7, Brima Kargbo10, David K Kargbo10, David Avram Sanders11, Gary P Kobinger4

Author Affiliations

1: Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA mto@umn.edu.
2: Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.
3: Division of Environmental and Occupational Health Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
4: National Laboratory for Zoonotic Diseases and Special Pathogens, Public Health Agency of Canada, Winnipeg, Canada.
5: The Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.
6: Sabin Vaccine Institute, Washington, DC, USA.
7: Medical Department Unit, Médecins sans Frontières, Brussels, Belgium.
8: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
9: Ministry of Health, Kinshasa, Democratic Republic of the Congo.
10: Ministry of Health and Sanitation, Freetown, Sierra Leone.
11: Department of Biological Sciences, Purdue University, Lafayette, Indiana, USA.

Articles citing this

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak. Clin Ther (2015) 1.16

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet (2016) 1.08

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. J Clin Invest (2015) 0.99

Ebola Virus in Breast Milk in an Ebola Virus-Positive Mother with Twin Babies, Guinea, 2015. Emerg Infect Dis (2016) 0.85

A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open (2015) 0.85

Integrative modelling for One Health: pattern, process and participation. Philos Trans R Soc Lond B Biol Sci (2017) 0.84

Distinguishing epidemiological features of the 2013-2016 West Africa Ebola virus disease outbreak. Disaster Health (2016) 0.79

Immunological features underlying viral hemorrhagic fevers. Curr Opin Immunol (2015) 0.79

The Role of the Polio Program Infrastructure in Response to Ebola Virus Disease Outbreak in Nigeria 2014. J Infect Dis (2016) 0.78

A Review of the Role of Food and the Food System in the Transmission and Spread of Ebolavirus. PLoS Negl Trop Dis (2015) 0.78

Partitioning of Viruses in Wastewater Systems and Potential for Aerosolization. Environ Sci Technol Lett (2016) 0.78

Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques. J Infect Dis (2016) 0.78

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. J Infect Dis (2016) 0.76

Aerosol Transmission of Filoviruses. Viruses (2016) 0.76

Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination. Sci Rep (2017) 0.75

Effectively Communicating the Uncertainties Surrounding Ebola Virus Transmission. PLoS Pathog (2015) 0.75

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge. PLoS One (2016) 0.75

Factors determining human-to-human transmissibility of zoonotic pathogens via contact. Curr Opin Virol (2016) 0.75

Virucidal activity of WHO-recommended formulations against enveloped viruses including Zika, Ebola and emerging Coronaviruses. J Infect Dis (2017) 0.75

The snot-spattered experiments that show how far sneezes really spread. Nature (2016) 0.75

Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient. PLoS Pathog (2017) 0.75

Follow-up of Ebola Patient, 2014-2015. Emerg Infect Dis (2016) 0.75

Ebola virus disease and the veterinary perspective. Ann Clin Microbiol Antimicrob (2015) 0.75

Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. J Infect Dis (2017) 0.75

Ebola virus disease: Essential clinical knowledge. Avicenna J Med (2017) 0.75

Operational Research during the Ebola Emergency. Emerg Infect Dis (2017) 0.75

The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous. Diagn Microbiol Infect Dis (2017) 0.75

Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys. J Virol (2017) 0.75

Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One (2017) 0.75

Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLoS One (2017) 0.75

Articles cited by this

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65

Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science (2014) 12.99

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control (2007) 12.37

Fruit bats as reservoirs of Ebola virus. Nature (2005) 11.05

Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ (1978) 9.23

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72

Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59

Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis (2007) 6.46

Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol (2004) 5.86

Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ (1978) 5.82

Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49

Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20

Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81

Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 4.67

A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57

Ebola virus disease in West Africa--no early end to the outbreak. N Engl J Med (2014) 4.48

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28

Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis (2009) 4.24

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77

Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55

Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis (2011) 3.45

Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36

Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch Virol Suppl (2008) 3.22

Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis (2010) 2.90

Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep (2001) 2.79

Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis (2003) 2.61

Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol (1995) 2.56

Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet (1996) 2.45

The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med (1997) 2.45

Ebola virus outbreak among wild chimpanzees living in a rain forest of Côte d'Ivoire. J Infect Dis (1999) 2.34

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27

Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med (1996) 2.23

Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22

Ebola virus disease in the Democratic Republic of Congo. N Engl J Med (2014) 2.19

Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis (2011) 2.10

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04

Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med (2000) 2.03

Ebola virus disease cases among health care workers not working in Ebola treatment units--Liberia, June-August, 2014. MMWR Morb Mortal Wkly Rep (2014) 2.02

Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. J Infect Dis (1999) 1.92

Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol (2015) 1.91

Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.88

The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol (2010) 1.88

Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86

Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86

Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol (1999) 1.83

Transmission of Ebola virus from pigs to non-human primates. Sci Rep (2012) 1.66

Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62

Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis (2011) 1.58

A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect (2003) 1.57

Airborne transmission of communicable infection--the elusive pathway. N Engl J Med (2004) 1.52

The role of particle size in aerosolised pathogen transmission: a review. J Infect (2010) 1.50

Ebola virus disease cluster in the United States--Dallas County, Texas, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.49

Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol (2003) 1.45

Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror (2004) 1.34

Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch Virol (2010) 1.29

Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Arch Virol (2010) 1.27

Insights into the early epidemic spread of ebola in sierra leone provided by viral sequence data. PLoS Curr (2014) 1.23

The first case of Ebola virus disease acquired outside Africa. N Engl J Med (2014) 1.20

Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis (2011) 1.20

Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Wkly Epidemiol Rec (2003) 1.10

Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques. Vet Pathol (2012) 1.09

Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis (2005) 1.08

Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectious respiratory disease management. BMC Pulm Med (2012) 1.04

Phylodynamic analysis of ebola virus in the 2014 sierra leone epidemic. PLoS Curr (2014) 1.03

Ebola virus transmission in guinea pigs. J Virol (2014) 1.01

Preparing for critical care services to patients with Ebola. Ann Intern Med (2014) 0.98

Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis (2015) 0.94

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep (2014) 0.92

Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec (1992) 0.90

Experimental aerosolized guinea pig-adapted Zaire ebolavirus (variant: Mayinga) causes lethal pneumonia in guinea pigs. Vet Pathol (2014) 0.86

Ebola virus transmission. Int J Exp Pathol (1995) 0.79